22-26540985-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003595.5(TPST2):āc.646A>Gā(p.Lys216Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 152,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003595.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPST2 | NM_003595.5 | c.646A>G | p.Lys216Glu | missense_variant | 3/7 | ENST00000338754.9 | NP_003586.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPST2 | ENST00000338754.9 | c.646A>G | p.Lys216Glu | missense_variant | 3/7 | 1 | NM_003595.5 | ENSP00000339813.4 | ||
TPST2 | ENST00000398110.6 | c.646A>G | p.Lys216Glu | missense_variant | 3/7 | 2 | ENSP00000381180.2 | |||
TPST2 | ENST00000403880.5 | c.646A>G | p.Lys216Glu | missense_variant | 4/8 | 5 | ENSP00000385192.1 | |||
TPST2 | ENST00000454778.6 | c.646A>G | p.Lys216Glu | missense_variant | 3/7 | 4 | ENSP00000400357.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 33
GnomAD4 exome Cov.: 34
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2023 | The c.646A>G (p.K216E) alteration is located in exon 3 (coding exon 1) of the TPST2 gene. This alteration results from a A to G substitution at nucleotide position 646, causing the lysine (K) at amino acid position 216 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at